Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know
2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Headwinds
2 Healthcare Stocks to Target This Week and 1 That Underwhelm
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know
New registry study data shows that long-term use of Dexcom G7 supports weight management and lowers A1C for people with Type 2 diabetes who aren’t on insulin therapy 1 , ...
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know
/Dexcom%20Inc%20logo%20on%20sign-by%20Michael%20Vi%20via%20Shutterstock.jpg)
DexCom has underperformed the Nasdaq Composite over the past year, yet analysts remain highly optimistic about the stock’s future.
1 Nasdaq 100 Stock with Impressive Fundamentals and 2 We Avoid
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Rick Osterloh to its Board of Directors, effective February 26, 2026. Mr. Osterloh is a...
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 47 th Annual Raymond James Institutional Investors Conference on Monday, March...